Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
wolf-screen-ratio-mammosphere-adherent | 0.938 | 1.21e-15 | 2.30e-03 | 3.80e-02 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
TUBG1 | 7283 | 3 | 0.974 | 0.938 | 55 | Yes | - |
RPA2 | 6118 | 98 | 1.250 | 1.151 | 69 | Yes | - |
ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - |
CASP8 | 841 | 8 | 0.804 | 1.041 | 141 | - | - |
[ KRT18 ] | 3875 | 1 | -0.353 | 0.938 | 94 | - | Yes |
RBX1 | 9978 | 97 | 1.185 | 1.151 | 139 | Yes | - |
RPSA | 3921 | 156 | 1.327 | 1.151 | 152 | Yes | - |
ORC5 | 5001 | 2 | -0.461 | 0.992 | 31 | - | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ORC5 | 5001 | RPA2 | 6118 | pp | -- | int.I2D: BioGrid |
KRT18 | 3875 | TUBG1 | 7283 | pp | -- | int.I2D: HPRD, BIND; int.HPRD: in vivo |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
CASP8 | 841 | KRT18 | 3875 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro |
KRT18 | 3875 | ORC5 | 5001 | pp | -- | int.Intact: MI:0915(physical association) |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0097284 | hepatocyte apoptotic process | 9.67e-06 | 1.40e-01 | 8.646 | 2 | 3 | 9 |
GO:0031625 | ubiquitin protein ligase binding | 9.89e-05 | 1.00e+00 | 4.925 | 3 | 14 | 178 |
GO:0016032 | viral process | 1.15e-04 | 1.00e+00 | 3.755 | 4 | 55 | 534 |
GO:0097110 | scaffold protein binding | 1.50e-04 | 1.00e+00 | 6.729 | 2 | 3 | 34 |
GO:0097191 | extrinsic apoptotic signaling pathway | 1.87e-04 | 1.00e+00 | 6.568 | 2 | 3 | 38 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0030690 | Noc1p-Noc2p complex | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0070243 | regulation of thymocyte apoptotic process | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0005515 | protein binding | 9.24e-04 | 1.00e+00 | 1.260 | 8 | 184 | 6024 |
GO:0000278 | mitotic cell cycle | 1.00e-03 | 1.00e+00 | 3.790 | 3 | 48 | 391 |
GO:0005200 | structural constituent of cytoskeleton | 1.08e-03 | 1.00e+00 | 5.308 | 2 | 8 | 91 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0005815 | microtubule organizing center | 1.54e-03 | 1.00e+00 | 5.048 | 2 | 5 | 109 |
GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0036462 | TRAIL-activated apoptotic signaling pathway | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0005654 | nucleoplasm | 1.73e-03 | 1.00e+00 | 2.737 | 4 | 76 | 1082 |
GO:0006260 | DNA replication | 1.89e-03 | 1.00e+00 | 4.897 | 2 | 9 | 121 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0035877 | death effector domain binding | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 3 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 2 | 5 |
GO:0005827 | polar microtubule | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0032025 | response to cobalt ion | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.85e-03 | 1.00e+00 | 4.597 | 2 | 32 | 149 |
GO:0003688 | DNA replication origin binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 6 |
GO:0031265 | CD95 death-inducing signaling complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0031264 | death-inducing signaling complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0000808 | origin recognition complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0060546 | negative regulation of necroptotic process | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0097342 | ripoptosome | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0000028 | ribosomal small subunit assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0000930 | gamma-tubulin complex | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 7 |
GO:0032403 | protein complex binding | 4.26e-03 | 1.00e+00 | 4.300 | 2 | 10 | 183 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 2 | 8 |
GO:0097202 | activation of cysteine-type endopeptidase activity | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0005664 | nuclear origin of replication recognition complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 2 | 8 |
GO:0005737 | cytoplasm | 5.35e-03 | 1.00e+00 | 1.522 | 6 | 110 | 3767 |
GO:0005829 | cytosol | 5.45e-03 | 1.00e+00 | 1.853 | 5 | 132 | 2496 |
GO:0001841 | neural tube formation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0005662 | DNA replication factor A complex | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0045104 | intermediate filament cytoskeleton organization | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 4 | 14 |
GO:0007020 | microtubule nucleation | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 14 |
GO:0034451 | centriolar satellite | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 15 |
GO:0005123 | death receptor binding | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 15 |
GO:0006281 | DNA repair | 8.50e-03 | 1.00e+00 | 3.788 | 2 | 18 | 261 |
GO:0050998 | nitric-oxide synthase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0030101 | natural killer cell activation | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 2 | 16 |
GO:0031122 | cytoplasmic microtubule organization | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 18 |
GO:0035861 | site of double-strand break | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 18 |
GO:0097194 | execution phase of apoptosis | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0005856 | cytoskeleton | 1.05e-02 | 1.00e+00 | 3.631 | 2 | 12 | 291 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.05e-02 | 1.00e+00 | 6.568 | 1 | 1 | 19 |
GO:0006298 | mismatch repair | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 3 | 20 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 5 | 21 |
GO:0045862 | positive regulation of proteolysis | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 4 | 21 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 3 | 22 |
GO:0030863 | cortical cytoskeleton | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 22 |
GO:0006270 | DNA replication initiation | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 6 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 4 | 23 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0071944 | cell periphery | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0000794 | condensed nuclear chromosome | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 24 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 3 | 25 |
GO:0000722 | telomere maintenance via recombination | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 5 | 25 |
GO:0042113 | B cell activation | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 25 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 4 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 3 | 26 |
GO:0009409 | response to cold | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 26 |
GO:0043022 | ribosome binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 3 | 27 |
GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0034612 | response to tumor necrosis factor | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 4 | 27 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 28 |
GO:0019894 | kinesin binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0019005 | SCF ubiquitin ligase complex | 1.60e-02 | 1.00e+00 | 5.958 | 1 | 1 | 29 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 7 | 30 |
GO:0005164 | tumor necrosis factor receptor binding | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 30 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 30 |
GO:0046677 | response to antibiotic | 1.71e-02 | 1.00e+00 | 5.862 | 1 | 2 | 31 |
GO:0001895 | retina homeostasis | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 34 |
GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 2 | 34 |
GO:0034332 | adherens junction organization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 36 |
GO:0008234 | cysteine-type peptidase activity | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 3 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 4 | 37 |
GO:0006284 | base-excision repair | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 3 | 37 |
GO:0045095 | keratin filament | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 1 | 37 |
GO:0071407 | cellular response to organic cyclic compound | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 4 | 39 |
GO:0000781 | chromosome, telomeric region | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 3 | 39 |
GO:0042110 | T cell activation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 3 | 42 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.36e-02 | 1.00e+00 | 5.390 | 1 | 4 | 43 |
GO:0021762 | substantia nigra development | 2.42e-02 | 1.00e+00 | 5.357 | 1 | 2 | 44 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 7 | 46 |
GO:0044297 | cell body | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 2 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 2.58e-02 | 1.00e+00 | 5.261 | 1 | 5 | 47 |
GO:0044267 | cellular protein metabolic process | 2.65e-02 | 1.00e+00 | 2.927 | 2 | 29 | 474 |
GO:0003684 | damaged DNA binding | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 7 | 49 |
GO:0004197 | cysteine-type endopeptidase activity | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 3 | 50 |
GO:0000226 | microtubule cytoskeleton organization | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 3 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 5 | 53 |
GO:0008233 | peptidase activity | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 54 |
GO:0045216 | cell-cell junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 54 |
GO:0097193 | intrinsic apoptotic signaling pathway | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 55 |
GO:0000724 | double-strand break repair via homologous recombination | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 3 | 55 |
GO:0051291 | protein heterooligomerization | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 56 |
GO:0000723 | telomere maintenance | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 6 | 56 |
GO:0005882 | intermediate filament | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 2 | 61 |
GO:0019903 | protein phosphatase binding | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 4 | 62 |
GO:0006302 | double-strand break repair | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 4 | 62 |
GO:0071260 | cellular response to mechanical stimulus | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 5 | 65 |
GO:0006289 | nucleotide-excision repair | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 5 | 68 |
GO:0032355 | response to estradiol | 3.87e-02 | 1.00e+00 | 4.666 | 1 | 5 | 71 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 6 | 74 |
GO:0045087 | innate immune response | 4.05e-02 | 1.00e+00 | 2.597 | 2 | 24 | 596 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 2 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 4.14e-02 | 1.00e+00 | 4.568 | 1 | 3 | 76 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 7 | 77 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 3 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 3 | 79 |
GO:0019083 | viral transcription | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 10 | 81 |
GO:0009653 | anatomical structure morphogenesis | 4.51e-02 | 1.00e+00 | 4.441 | 1 | 3 | 83 |
GO:0047485 | protein N-terminus binding | 4.67e-02 | 1.00e+00 | 4.390 | 1 | 5 | 86 |
GO:0045471 | response to ethanol | 4.67e-02 | 1.00e+00 | 4.390 | 1 | 3 | 86 |
GO:0006415 | translational termination | 4.73e-02 | 1.00e+00 | 4.373 | 1 | 10 | 87 |
GO:0016605 | PML body | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 3 | 88 |
GO:0006928 | cellular component movement | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 7 | 91 |
GO:0071456 | cellular response to hypoxia | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 6 | 92 |
GO:0006414 | translational elongation | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 13 | 93 |
GO:0034142 | toll-like receptor 4 signaling pathway | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 3 | 96 |
GO:0005730 | nucleolus | 5.31e-02 | 1.00e+00 | 1.721 | 3 | 69 | 1641 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 10 | 104 |
GO:0014069 | postsynaptic density | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 105 |
GO:0005741 | mitochondrial outer membrane | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 7 | 105 |
GO:0002224 | toll-like receptor signaling pathway | 5.89e-02 | 1.00e+00 | 4.048 | 1 | 3 | 109 |
GO:0072562 | blood microparticle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 8 | 112 |
GO:0097190 | apoptotic signaling pathway | 6.10e-02 | 1.00e+00 | 3.996 | 1 | 6 | 113 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.15e-02 | 1.00e+00 | 3.983 | 1 | 11 | 114 |
GO:0019058 | viral life cycle | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 13 | 115 |
GO:0006325 | chromatin organization | 6.36e-02 | 1.00e+00 | 3.933 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 6.47e-02 | 1.00e+00 | 3.909 | 1 | 5 | 120 |
GO:0032496 | response to lipopolysaccharide | 6.52e-02 | 1.00e+00 | 3.897 | 1 | 4 | 121 |
GO:0000790 | nuclear chromatin | 6.94e-02 | 1.00e+00 | 3.805 | 1 | 9 | 129 |
GO:0006413 | translational initiation | 7.04e-02 | 1.00e+00 | 3.783 | 1 | 17 | 131 |
GO:0000086 | G2/M transition of mitotic cell cycle | 7.30e-02 | 1.00e+00 | 3.729 | 1 | 9 | 136 |
GO:0003735 | structural constituent of ribosome | 7.35e-02 | 1.00e+00 | 3.718 | 1 | 10 | 137 |
GO:0007507 | heart development | 7.46e-02 | 1.00e+00 | 3.697 | 1 | 7 | 139 |
GO:0006457 | protein folding | 7.66e-02 | 1.00e+00 | 3.656 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 7.77e-02 | 1.00e+00 | 3.636 | 1 | 7 | 145 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 7.77e-02 | 1.00e+00 | 3.636 | 1 | 4 | 145 |
GO:0005198 | structural molecule activity | 8.03e-02 | 1.00e+00 | 3.587 | 1 | 5 | 150 |
GO:0045121 | membrane raft | 8.33e-02 | 1.00e+00 | 3.531 | 1 | 8 | 156 |
GO:0043005 | neuron projection | 8.39e-02 | 1.00e+00 | 3.521 | 1 | 6 | 157 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.80e-02 | 1.00e+00 | 3.450 | 1 | 7 | 165 |
GO:0030424 | axon | 8.85e-02 | 1.00e+00 | 3.441 | 1 | 4 | 166 |
GO:0007049 | cell cycle | 9.26e-02 | 1.00e+00 | 3.373 | 1 | 2 | 174 |
GO:0001525 | angiogenesis | 1.01e-01 | 1.00e+00 | 3.239 | 1 | 4 | 191 |
GO:0003924 | GTPase activity | 1.04e-01 | 1.00e+00 | 3.194 | 1 | 12 | 197 |
GO:0044822 | poly(A) RNA binding | 1.12e-01 | 1.00e+00 | 1.772 | 2 | 49 | 1056 |
GO:0006184 | GTP catabolic process | 1.13e-01 | 1.00e+00 | 3.075 | 1 | 12 | 214 |
GO:0016071 | mRNA metabolic process | 1.17e-01 | 1.00e+00 | 3.015 | 1 | 31 | 223 |
GO:0006412 | translation | 1.21e-01 | 1.00e+00 | 2.971 | 1 | 20 | 230 |
GO:0016070 | RNA metabolic process | 1.29e-01 | 1.00e+00 | 2.868 | 1 | 32 | 247 |
GO:0004842 | ubiquitin-protein transferase activity | 1.33e-01 | 1.00e+00 | 2.822 | 1 | 6 | 255 |
GO:0070062 | extracellular vesicular exosome | 1.34e-01 | 1.00e+00 | 1.172 | 3 | 104 | 2400 |
GO:0000166 | nucleotide binding | 1.35e-01 | 1.00e+00 | 2.799 | 1 | 5 | 259 |
GO:0019899 | enzyme binding | 1.44e-01 | 1.00e+00 | 2.702 | 1 | 12 | 277 |
GO:0043234 | protein complex | 1.52e-01 | 1.00e+00 | 2.612 | 1 | 18 | 295 |
GO:0016567 | protein ubiquitination | 1.52e-01 | 1.00e+00 | 2.612 | 1 | 5 | 295 |
GO:0005524 | ATP binding | 1.58e-01 | 1.00e+00 | 1.474 | 2 | 60 | 1298 |
GO:0005525 | GTP binding | 1.60e-01 | 1.00e+00 | 2.540 | 1 | 12 | 310 |
GO:0019901 | protein kinase binding | 1.63e-01 | 1.00e+00 | 2.508 | 1 | 21 | 317 |
GO:0007411 | axon guidance | 1.64e-01 | 1.00e+00 | 2.499 | 1 | 13 | 319 |
GO:0005813 | centrosome | 1.67e-01 | 1.00e+00 | 2.467 | 1 | 14 | 326 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.300 | 1 | 19 | 366 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 6 | 369 |
GO:0006508 | proteolysis | 1.91e-01 | 1.00e+00 | 2.254 | 1 | 9 | 378 |
GO:0046982 | protein heterodimerization activity | 1.92e-01 | 1.00e+00 | 2.246 | 1 | 13 | 380 |
GO:0043066 | negative regulation of apoptotic process | 2.12e-01 | 1.00e+00 | 2.088 | 1 | 31 | 424 |
GO:0003674 | molecular_function | 2.21e-01 | 1.00e+00 | 2.022 | 1 | 4 | 444 |
GO:0005634 | nucleus | 2.24e-01 | 1.00e+00 | 0.662 | 4 | 136 | 4559 |
GO:0007596 | blood coagulation | 2.26e-01 | 1.00e+00 | 1.986 | 1 | 18 | 455 |
GO:0016020 | membrane | 2.37e-01 | 1.00e+00 | 1.101 | 2 | 90 | 1681 |
GO:0048471 | perinuclear region of cytoplasm | 2.47e-01 | 1.00e+00 | 1.845 | 1 | 13 | 502 |
GO:0006915 | apoptotic process | 2.69e-01 | 1.00e+00 | 1.700 | 1 | 33 | 555 |
GO:0010467 | gene expression | 3.16e-01 | 1.00e+00 | 1.430 | 1 | 59 | 669 |
GO:0005615 | extracellular space | 4.23e-01 | 1.00e+00 | 0.914 | 1 | 17 | 957 |
GO:0008270 | zinc ion binding | 4.36e-01 | 1.00e+00 | 0.855 | 1 | 12 | 997 |
GO:0005739 | mitochondrion | 4.37e-01 | 1.00e+00 | 0.853 | 1 | 28 | 998 |
GO:0005886 | plasma membrane | 7.94e-01 | 1.00e+00 | -0.518 | 1 | 45 | 2582 |